Delivery Order SPE2DB20D9371-SPE2DB25FT1X2

Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,407.12 contract is to provide 4,564,856,921 units of Terbinafine HCl 250 mg tablets. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue firm...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,111.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical products, including branded and generic prescription...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $1,407.12 contract is for the delivery of 4,564,928,264 tablets of the prescription drug terbinafine hydrochloride 250 mg, with a performance period through May 17, 2024. The award is under a larger indefinite delivery contract (IDC) with DMS Pharmaceutical valued at up to $499,999,999. This IDC, part of the DLA's SPE2DB program, allows the...
This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,333.12 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on May 10, 2024 and has a performance period through May 13, 2024. The contract provides the DLA with 4564614684 - Terbinafine HCL 250 mg tablet (90 count) to support the medical supply needs of military health facilities. This award is part of DMS...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4,568,168,535 units of Terbinafine Hydrochloride 250 mg tablets. The $2,111.04 firm-fixed-price delivery order has a completion date of May 6, 2025 and is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with DLA under the SPE2DB program. This IDC enables DLA to issue delivery orders for a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,505.00, is for the delivery of Terbinafine cream, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger, single-award indefinite delivery contract (IDC) with...
This is a federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $1,254.62, is for the delivery of Terbinafine cream to support the recurring medical supply needs of military health facilities. The contract, a firm fixed-price delivery order (SPE2DX23FTRNV) under the Defense Logistics Agency's (DLA) Medical Supply Chain program, has an ultimate completion date of August 14, 2023. DMS...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The $1,423.89 order is for the supply of Terbinafine Cream HCL, a topical antifungal medication. DMS Pharmaceutical Group holds multiple contracts and indefinite delivery vehicles with DLA to provide a variety of pharmaceutical and medical products to military treatment facilities worldwide. This specific delivery order is...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract, valued at $2,252.50, is for the delivery of terbinafine cream (TERBINAFINE CREAM 4565594105) to support the recurring medical supply needs of military health facilities worldwide. The contract is part of a larger $499,999,999 indefinite delivery contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,464.60, is for the supply of TERBINAFINE CREAM HCL, a pharmaceutical product. The contract has a firm fixed-price pricing structure and an ultimate completion date of August 28, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with...
  • SPE2DB20D9371
    Indefinite Delivery Contract
  • SPE2DB20D9371-SPE2DB25FT1X2
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,289.86 contract is for the delivery of 4,568,381,610 units of the prescription medication Terbinafine HCl 250 mg tablets by May 29, 2025.

DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories.

Generated 8/31/25, 1:11 AM